Abstract
Umbilical cord blood is an important graft source in the treatment of many genetic, hematologic, and immunologic disorders by hematopoietic stem cell transplantation. Millions of cord blood units have been collected and stored for clinical use since the inception of cord blood banking in 1989. However, the use of cord blood in biomedical research has been limited by access to viable samples. Here, we present a cost-effective, self-sustaining model for the procurement of fresh umbilical cord blood components for research purposes within hospital-affiliated academic institutions.
Keywords:
Cord blood banking; Hematopoietic stem cell; The Binns Program; Umbilical cord; Umbilical cord blood.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Academies and Institutes / economics
-
Academies and Institutes / organization & administration
-
Academies and Institutes / standards
-
Biomedical Research / economics
-
Biomedical Research / methods
-
Biomedical Research / organization & administration*
-
Biomedical Research / standards
-
Blood Banks / economics
-
Blood Banks / organization & administration*
-
Blood Banks / standards
-
Blood Specimen Collection / economics
-
Blood Specimen Collection / methods
-
Blood Specimen Collection / standards
-
California
-
Cost-Benefit Analysis
-
Female
-
Fetal Blood* / cytology
-
Fetal Blood* / transplantation
-
Hematopoietic Stem Cell Transplantation / economics
-
Hematopoietic Stem Cell Transplantation / methods
-
Hematopoietic Stem Cell Transplantation / standards
-
Humans
-
Infant, Newborn
-
Models, Organizational*
-
Pregnancy